Member Info for GloriaMarket

"My one fear is that they announce a January placing (Q1) in December, so I’m a little cautious at the moment."

I doubt they will find an ii that quickly tbh. RF and the death spiral probably involve a great many potential legal complications that would need to be thrashed out and resolved first. I doubt any ii will want to fund GDR with RF vulture circling above. I suspect they will even struggle to find an ii until RF are completely out of the picture.

"It just leaves EU orders starting this month, so we might hear something there"

Not just EU orders but also middle east (dubai was it?).

I think he sold at 5p on the morning that the annual report was published a couple of weeks ago.

"Bourght more after my mate in America just told me what well I cant say but let's just say anyone not in here loooooooooosers come on Genedrive"

I've just spoke to an acquaintance in EU, can't disclose what he said but suffice to say anyone investing in GDR right now will need deep pockets in order to afford averaging down in Q1

"What does he know that the plebs don't?"

Everything, he's the CEO. CEOs are not day traders of their own company. Would the CEO of GDR invest in GDR for the long term knowing that a large dilution is not only needed in Q1 but also the best case scenario?

"WHY buy now when you can get sub 5p in the New Year"

Because if you are a day trader you'll miss out on the RNS led pump and dumps. Assuming GDR will publish more good news between now and placement time...

"Placement time,

Mistletoe and wine,

Genedrive preventing,

Antibody-induced hearling loss"... altogether!

It's not a matter of IF you should invest in GDR, it's a matter of WHEN!!! Ask yourself, how greedy are you? Can you wait for a placement?

Each day Mr Nissan calls out a share price, completely at random (the number could be over 100!!).

The first poster to call house wins a tour of GDR's student laboratory.

" the magnitude of the news expected in the next couple of weeks"

That's what Mr Cheek stated. Sales in foreign countries expected in december because now medics have instructions written in the local language.

"Roger, GDR's commentary in the results RNS states they are looking for three sets of funding as I read it. One is for FDA (which they've previously said would cost about £2m, though this was some time ago when they gave that estimate.)

From 30 November RNS:

1. "The Group's current cash runway is limited...... further funding will be required in early 2024 in order to continue as a going concern."

2. "We are now looking at funding options to take us forward for FDA approval for the MT-RNR1 product, with substantially all of the exploratory groundwork completed we are ready to proceed to the next step."

3. "Future funding would also be required to support the ongoing development of the instrumentation allowing us to capitalise on our pharmacogenetic positioning in emergency care and add further tests to our existing menu.""

excellent post Mr Stocksaint/Starres , nice summary.

Just a word of caution. GDR sp rose significantly last week (high point of 11p?) and unsurprisingly we saw loads of new confident investors sharing their opinions on LSE (100% rampy opinions). GDR sp is now falling backand the new rampers have left the chat board (in general) , leaving the familiar posters to squabble amongst themselves, agai. This tells you all you need to know - GDR is day traders stock and more importantly, the upwards pressure has disipated as the smart money sold. Without any more news on sales this will drop back. As Mr StockSaint pointed out by simply watching the presentation and reding the RNS, within weeks there will be news of a placement (hopefully, otherwise GDR will cease to continue as an ongoing concern within 6 months, assuming RF do not permit drawdowns).

But those in manchester are collecting data on behalf of GDR i order to complete the NICE requirements so its unlikely that there is a commercial contract of any worth (perhaps this can be determined in the annual results, Ive not read them yet). Whereas the brighton hospital RNS suggests that they are a formal customer and a commerical contract with GDR has been signed.

Mr Stocksaint, that's true too, but Mr Cheek has shown he can at least sign up one hospital for AIHL, without being centrally funded.

"Because GDR were not talking to budget holders!!!"

Exactly. And if Mr Cheek is now talking to budget holders, as he stated clearly during the presentation. The hospital in brighton is now a customer, probably the first real customer GDR have had in 4 years. Action speak louder than words, in this case, Mr Cheek he's in a totally different league to Mr Budd.

Even if they sell up beofre placement is announced. After all a placement is the best case scenario, the worst case scenario is no placement and funds drying up May 2024. To be frank the best case scenario is that AIHL sales generate more than enough income for GDR to pay for the 400k a month cash burn and even make a profit.

20+M funding @ 1p is a bargain for GDR. Assuming the death spiral financing deal doesn't cause complications.

Mr Neil, Let me guess, you are a shareholder with an agenda.

"Gloria - be sensible. A raise at 1p would be a discount of over 80% and at a time when the future is starting to look bright."

GDR should therefore look for 3 years worthing funding and not the hand to mouth funding which Mr Budd profitted from (via bonus). The former CFO who left GDR for Music magpie joined because Music magpie had found 3 years worth of funding and wanted to grow. It's not impossible for GDR to do this. Which investors here would not approve of 3 years of funding worth 20+M? All LTHers are sitting on a loss right now, and have nothing more to lose. Mr Cheek should look for major long term funding at a bargain price.

"No need for placing as right now sitting with more than 2.5mil in account!!"

Oh, oh, here we go! lol There is even a section in the RNS about GDR not being able to continure as going concern unless funding is found in 1Q24. The share price is 6p and thats AFTER the good news in yesterdays RNS. But if Mr Cheek can get another 9 hospitals onboard... 6p sounds like a bargain. But then again funding is needed. If I was Mr Cheek, I'd choose a really low placement price of say 0.1p that is used to raise 20M (ie funding for the next 3 years), in order to see GDR through the 3 year wait until full NICE approval is given. .... Funding for just 1 year , as Mr budd enjoyed, is disrespectful not only to PI's but the NHS and GDRs own employees.

"GDR getting instituional funding won't be a problem with what they have."

I agree 100%. That a hospital is now onboard as a full customer , despite no dedicated funding for AIHL, is a great sign. Mr Cheek is expecting sales in EU and middle east. At the very least, this should stabilize the SP around 5-8p and increase volumes. Then the placement price will of course be made at a discount. I'd guess 5 million placement @1-2.5p due to urgency, pure guess based on the discounted price and value of previous placements.

"Good grief it's been a long time since GDR celebrated anything positive. I'd forgotten what it felt like !"

I totally agree with that!